medigraphic.com
Coordinación General de Investigación de la Facultad de Salud Pública y Nutrición y la Dirección General de Sistemas e Informática de la Universidad Autónoma de Nuevo León

2024, Number 4

<< Back Next >>

Rev Salud Publica Nutr 2024; 23 (4)

Analysis of interventions to improve hypertension treatment adherence in Latin America: a scoping review

García-López AC, Abril-Valdez E

Language: Spanish
References: 51
Page: 28-38
PDF size: 371.09 Kb.


ABSTRACT

Introduction: Lack of adherence to treatment represents a public health problem that has a direct impact on the health of the population. Objective: This review synthesizes findings of experimental studies to improve medication adherence and blood pressure control in the Latin American context. Material and method: A scoping literature review was conducted following the PRISMA for Scoping Reviews, a search and review of published studies was carried out, in the Latino population, from 2013 to 2023 in the MEDLINE (PubMed) Scielo and SCOPUS databases, in which the methodology for evaluating medication adherence and blood pressure control in patients with hypertension was analyzed. Results: 216 Latin American articles were identified, of which 57 were subject to eligibility evaluation, with 9 studies included in the review. Conclusion: The instruments to measure adherence to treatment were mainly self-reported questionnaires. Most of the studies included in this review report a low level of adherence associated with suboptimal clinical values. The most recent evidence has focused on addressing the problem of non-adherence with an educational/motivational approach, mainly through reminders on mobile devices.


REFERENCES

  1. Achury-Saldaña, D., Rodríguez, S. M., Achury-Beltrán, L.F., & Padilla-Velasco, M. P. (2013). Efecto de un planeducativo en la capacidad de agencia de autocuidadodel paciente con hipertensión arterial en una instituciónde segundo nivel. Aquichan, 13(3),363-372.https://aquichan.unisabana.edu.co/index.php/aquichan/article/view/2293/html

  2. Alhalaiqa, F., Deane, K. H. O., Nawafleh, A. H., Clark, A.,& Gray, R. (2012). Adherence therapy for medicationnon-compliant patients with hypertension: Arandomised controlled trial. Journal of HumanHypertension, 26(2), 117–126.DOI:10.1038/jhh.2010.133

  3. ALLHAT Officers and Coordinators for the ALLHATCollaborative Research Group. (2002). Majoroutcomes in high-risk hypertensive patientsrandomized to angiotensin-converting enzymeinhibitor or calcium channel blocker vs diuretic: TheAntihypertensive and Lipid-Lowering Treatment toPrevent Heart Attack Trial (ALLHAT). JAMA,288(23), 2981-2997. DOI: 10.1001/jama.288.23.2981

  4. Álvarez-Yáñez, D. M., & Reyes-González, C. X. (2022).Relación entre sobrecarga del cuidador y agencia deautocuidado del paciente de cirugía cardiaca enCúcuta, Colombia. Revista CUIDARTE13(2), 1-12.https://www.redalyc.org/articulo.oa?id=359573140017

  5. Berkman, N. D., DeWalt, D. A., Pignone, M. P., Sheridan,S. L., Lohr, K. N., Lux, L., et al. (2004). Literacy andhealth outcomes (Evidence Report/TechnologyAssessment No. 87). Agency for Healthcare Researchand Quality.https://corpora.tika.apache.org/base/docs/govdocs1/007/007074.pdf

  6. Beune, E. J. A. J., Moll van Charante, E. P., Beem, L.,Mohrs, J., Agyemang, C. O., Ogedegbe, G., &Haafkens, J. A. (2014). Culturally adaptedhypertension education to improve blood pressurecontrol and treatment adherence in patients of Africanorigin with uncontrolled hypertension: Clusterrandomized trial. PLoS ONE, 9(3),e90103. https://doi.org/10.1371/journal.pone.0090103

  7. Boutron I., Hoffmann T.C., Mulrow C.D. et al.(2021). The PRISMA 2020 statement: an updatedguideline for reporting systematic reviews BMJ; 372(71). https://doi.org/10.1136/bmj.n71

  8. Castro Espinosa, J., Molineros Gallón, L., Pino, M. E., &Osada, J. (2014). Adherencia terapéutica enhipertensión arterial sistémica y enfermedadcardiovascular: Factores asociados en adultos enChile. Revista de Salud Pública, 16(4), 509-521. https://doi.org/10.15446/rsap.v16n4.39816

  9. Chávez, O., Morales, G., Marcos, R., & Carpio, C. (2020).Adherencia terapéutica, interacción equipo médicopacientey justicia social en población indígenaMixteca de Guerrero, México. RevistaLatinoamericana de Bioética, 20(1).https://doi.org/10.18359/rlbi.4142

  10. Corrao, G., Parodi, A., Zambon, A., et al. (2010). Reduceddiscontinuation of antihypertensive treatment by twodrugcombination as first step: Evidence from daily lifepractice. Journal of Hypertension, 28, 1584-1590.DOI: 10.1097/HJH.0b013e328339f9fa

  11. Crespo Tejero, N., Rubio Franco, V. J., Casado Morales,M. I., Sánchez Martos, J., & Campo Sien, C. (2000).Factores moduladores de la adherencia farmacológicaen hipertensión arterial: Estudioexploratorio. Hipertensión y Riesgo Vascular,17(1). https://doi.org/10.1016/S1889-1837(00)71002-6

  12. Dailey, G., Kim, M. S., & Lian, J. F. (2001). Patientcompliance and persistence with antihyperglycemicdrug regimens: Evaluation of a Medicaid patientpopulation with type 2 diabetes mellitus. ClinicalTherapeutics, 23(6), 1211-1220.https://doi.org/10.1016/s0149-2918(01)80110-7

  13. Delavar, F., Pashaeypoor, S., & Negarandeh, R. (2019).The effects of self-management education tailored tohealth literacy on medication adherence and bloodpressure control among elderly people with primaryhypertension: A randomized controlled trial. PatientEducation and Counseling.https://doi.org/10.1016/j.pec.2019.08.028

  14. Díaz Piñera, A., Rodríguez Salvá, A., García Roche, R.,Carbonell García, I., & Achiong Estupiñán, F. (2018).Resultados de una intervención para la mejora delcontrol de la hipertensión arterial en cuatro áreas desalud. Revista Finlay, 8(3), 180-189.http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2221-24342018000300002

  15. Du, H. Y., Zecchin, N. P., Denniss, R., Salamonson, Y.,Everett, B., Currow, D., et al. (2011). An interventionto promote physical activity and self-management inpeople with stable chronic heart failure: The Home-Heart-Walk study: Study protocol for a randomizedcontrolled trial. Trials, 12, 63. DOI: 10.1186/1745-6215-12-63

  16. Gong, K., Yan, Y.-L., Li, Y., Du, J., Wang, J., Han, Y., &She, Q. (2020). Mobile health applications for themanagement of primary hypertension. Medicine,99(16), e19715.https://doi.org/10.1097/MD.0000000000019715

  17. He, J., Irazola, V., Mills, K. T., Poggio, R., Beratarrechea,A., Dolan, J., et al. (2017). Effect of a communityhealth worker–led multicomponent intervention onblood pressure control in low-income patients inArgentina. JAMA, 318(11), 1016.https://doi.org/10.1001/jama.2017.11358

  18. Higuera, E., Rojas, M., & Garzón, D. I. (2015).Experiencia de hipertensión arterial en la relaciónpaciente, familia y contexto de ayuda. Revista de SaludPública, 17(6), 874-885.https://doi.org/10.15446/rsap.v17n6.49228

  19. Hutton, B., Catalá-López, F., & Moher, D. (2016). Laextensión de la declaración PRISMA para revisionessistemáticas que incorporan metaanálisis en red:PRISMA-NMA. Medicina Clínica, 147(6), 262-266.https://doi.org/10.1016/j.medcli.2016.02.025

  20. Insel, K. C., Einstein, G. O., Morrow, D. G., Koerner, K.M., & Hepworth, J. T. (2016). Multifacetedprospective memory intervention to improvemedication adherence. Journal of the AmericanGeriatrics Society, 64(3), 561–568.https://doi.org/10.1111/jgs.14032

  21. Law, M. R. (2003). Value of low dose combinationtreatment with blood pressure lowering drugs:Analysis of 354 randomised trials. BMJ, 326, 1427-1430.

  22. Leong, D. P., Joseph, P. G., McKee, M., Anand, S. S., Teo,K. K., Schwalm, J. D., et al. (2017). Reducing theglobal burden of cardiovascular disease, part2. Circulation Research, 121(6), 695-710.https://doi.org/10.1161/CIRCRESAHA.117.311849

  23. Liu, L., Zhang, Y., Liu, G., et al. (2005). The FelodipineEvent Reduction (FEVER) Study: A randomized longtermplacebo-controlled trial in Chinese hypertensivepatients. Journal of Hypertension, 23, 2157-2172.DOI: 10.1097/01.hjh.0000194120.42722.ac

  24. Lozada, A., Piscoya, J., Shiraishi, C., & Mendieta, W.(2020). Calidad de vida y adherencia terapéutica en unprograma de hipertensión arterial. Revista de SaludPública, 22(6), 618-625. https://doi.org/10.15446/rsap.v22n6.88007

  25. Macquart, D., Kramoh, K. E., Bara Diop, I., Nhavoto, C.,Balde, D. M., Ferreira, B., et al. (2020). Poor adherenceto medication and salt restriction as a barrier toreaching blood pressure control in patients withhypertension: Cross-sectional study from 12 sub-Saharan countries. Archives of CardiovascularDiseases. https://doi.org/10.1016/j.acvd.2019.11.009

  26. Márquez Contreras, E., Márquez Rivero, S., RodríguezGarcía, E., López-García-Ramos, L., Pastoriza Vilas,J. C., & Baldonedo Suárez, A. (2018). Specifichypertension smartphone app to improve medicationadherence in hypertension: A cluster-randomizedtrial. Current Medical Research and Opinion, 1–15. https://doi.org/10.1080/03007995.2018.1549026

  27. Márquez-Hernández, V. V., Granados Gámez, G., &Roales-Nieto, J. G. (2015). Aplicación de un programade mejora de la adherencia en pacientes hipertensosdebutantes. Atención Primaria, 47(2), 83–89. https://doi.org/10.1016/j.aprim.2014.03.009

  28. Mejía, J., & Gómez, S. A. (2017). Trayectoria de vidafamiliar y estilos de vida: Hipertensión arterial ydiabetes mellitus II. Revista de Salud Pública, 19(3),

  29. 291-296. https://doi.org/10.15446/rsap.v19n3.3558129. Mills, K. T., Bundy, J. D., Kelly, T. N., et al. (2016). Globaldisparities of hypertension prevalence and control: Asystematic analysis of population-based studies from90 countries. Circulation, 134(6), 441-450. https://doi.org/10.1161/CIRCULATIONAHA.115.018912

  30. Nogués, X., Sorli, M. L., & Villar, J. (2007). Instrumentosde medida de adherencia al tratamiento. Anales deMedicina Interna, 24(3), 138-141. http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S021271992007000300009&lng=es&tlng=es

  31. Nolan, R. P., Feldman, R., Dawes, M., Kaczorowski, J.,Lynn, H., Barr, S. I., et al. (2018). Randomizedcontrolled trial of e-counseling forhypertension. Circulation: Cardiovascular Qualityand Outcomes, 11(7),e004420. https://doi.org/10.1161/CIRCOUTCOMES.117.004420

  32. van Onzenoort, H. A. W., Verberk, W. J., Kroon, A. A.,Kessels, A. G. H., Neef, C., van der Kuy, P.-H. M., &de Leeuw, P. W. (2012). Electronic monitoring ofadherence, treatment of hypertension, and bloodpressure control. American Journal of Hypertension,25(1), 54–59. https://doi.org/10.1038/ajh.2011.153

  33. Ortiz Vázquez, D., Bandera Ramírez, M., GonzálezGámez, S., Figueroa Sarmiento, L. D., & Veloz, V. E.(2019). Adherencia terapéutica y conocimientos sobrehipertensión arterial en una muestra de pacientesadultos. MEDISAN, 23(4), 632-643. https://www.redalyc.org/articulo.oa?id=368460425004

  34. Patel, A. (2007). Effects of a fixed combination ofperindopril and indapamide on macrovascular andmicrovascular outcomes in patients with type 2diabetes mellitus (the ADVANCE trial): A randomisedcontrolled trial. The Lancet, 370, 829-840.DOI: 10.1016/S0140-6736(07)61303-8

  35. Persell, S. D., Peprah, Y. A., Lipiszko, D., Lee, J. Y., Li, J.J., Ciolino, J. D., et al. (2020). Effect of home bloodpressure monitoring via a smartphone hypertensioncoaching application or tracking application on adultswith uncontrolled hypertension. JAMA Network Open,3(3),e200255. https://doi.org/10.1001/jamanetworkopen.2020.0255

  36. PRISMA (s.f.). PRISMA 2020 statement. The PRISMAGroup. https://www.prisma-statement.org/

  37. Reiger, S., Harris, J. R., Chan, K. C. G., Oqueli, H. L., &Kohn, M. (2015). A community-driven hypertensiontreatment group in rural Honduras. Global HealthAction, 8(1),28041. https://doi.org/10.3402/gha.v8.28041

  38. Restrepo, M. C., & Maya, A. M. (2020). “Estableciendovínculos dialógicos que alivian”: Una mirada desde elpatrón estético. Revista CUIDARTE, 11(2), 1-11. https://www.redalyc.org/articulo.oa?id=359565318015

  39. Rezende, R., Assumpção, D., & Stolses, P. M. (2021).Hipertensión arterial autorreferida en adultos mayoresbrasileños: Uso de medicación y recomendaciones parael control. Revista de Salud Pública, 23(4), 1-8. https://doi.org/10.15446/rsap.v23n4.93287

  40. Rivas, G. M., Pino, M. E., Díaz, C., & Osada, J. (2022).Efecto del uso de mensajes de texto en dispositivos detelefonía móvil en la adherencia al tratamiento dehipertensión arterial. Revista Cubana de Informaciónen Ciencias de la Salud,33. https://www.redalyc.org/articulo.oa?id=40823252012

  41. Romero, G. S. L., Parra, D. I., Sánchez, R. J. M., & Rojas,L. Z. (2017). Adherencia terapéutica de pacientes conhipertensión arterial y diabetes mellitus tipo 2 deBucaramanga, Colombia. Revista de la UniversidadIndustrial de Santander. Salud, 49(1), 37-44. https://www.redalyc.org/articulo.oa?id=343850079005

  42. Saleem, F., Hassali, M. A., Shafie, A. A., Ul Haq, N.,Farooqui, M., Aljadhay, H., & Ahmad, F. U. D. (2013).Pharmacist intervention in improving hypertensionrelatedknowledge, treatment medication adherenceand health-related quality of life: A non-clinicalrandomized controlled trial. Health Expectations,18(5), 1270–1281. https://doi.org/10.1111/hex.12101

  43. Sandoval, D., Chacón, J., Muñoz, R., Henríquez, O., Koch,E., & Romero, T. (2014). Influencia de factorespsicosociales en la adherencia al tratamientofarmacológico antihipertensivo. Resultados de unacohorte del Programa de Salud Cardiovascular de laRegión Metropolitana, Chile. Revista Médica de Chile,142, 1245-1252. https://doi.org/10.4067/S0034-98872014001000003

  44. Sever, P., Dahlof, B., Poulter, N., et al. (2006). Potentialsynergy between lipid-lowering and blood-pressureloweringin the Anglo-Scandinavian CardiacOutcomes Trial. European Heart Journal, 27, 2982-2988. DOI: 10.1093/eurheartj/ehl403

  45. Soler-Sánchez, K. R., Soler-Sánchez, Y. M., Pérez-Rosabal, E., Rodríguez-Rodríguez, D. R., &Castañeda-Castro, M. (2021). Programa educativo parafavorecer la adherencia terapéutica en pacienteshipertensos de Manzanillo. Revista InformaciónCientífica, 100(3).http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1028-99332021000300007

  46. Soto, A., Avila, X., Cordova, P., Fernandez, P., Lopez, M.,Villa, L. A., & Morales, F. (2015). Impact of apharmacotherapy plan to improve adherence forpatients with type-2 diabetes and hypertension in aChilean hospital. International Journal of ClinicalPharmacy, 37(5), 734-738. https://doi.org/10.1007/s11096-015-0131-2

  47. Svarstad, B. L., Kotchen, J. M., Shireman, T. I., Brown, R.L., Crawford, S. Y., Mount, J. K., & Wilson, D. A.(2013). Improving refill adherence and hypertensioncontrol in black patients: Wisconsin TEAMtrial. Journal of the American PharmacistsAssociation, 53(5), 520–529. https://doi.org/10.1331/JAPhA.2013.12246

  48. Teixeira Medeiros, N., & Magalhães Moreira, T. M.(2012). Avaliação de risco coronariano, adesãoterapêutica e qualidade de vida de idosos comhipertensão arterial. Revista Brasileira em Promoçãoda Saúde, 25(2), 76-82. https://www.redalyc.org/articulo.oa?id=40823252012

  49. Varleta, P., Acevedo, M., Akel, C., Salinas, C., Navarrete,C., García, A., & Romero, K. (2017). Lack ofknowledge about hypertension and its treatment: Abarrier to effective control. The Journal of ClinicalHypertension, 19(12), 1276-1284. https://doi.org/10.1111/jch.13098

  50. Velandia, A., & Rivera, L. N. (2009). Agencia deautocuidado y adherencia al tratamiento en personascon factores de riesgo cardiovascular. Revista de SaludPública, 11(4), 538-548. https://doi.org/10.1590/S0124-00642009000400005

  51. World Heart Federation. (2016, junio). World Congress ofCardiology & Cardiovascular Health, MéxicoCity. http://www.who.int/healthinfo/global_burden_disease/metrics_daly/en/




2020     |     www.medigraphic.com